Does Rallies show 13F holders for SOLV?

Yes. Rallies tracks hedge fund and 13F ownership data for SOLV, including fund names, share counts, latest tracked quarter, and position changes when available.

Is SOLV research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SOLV. It does not provide personalized investment advice.

SOLV (Solventum Corporation) Stock Analysis - Hedge Fund Holdings

Solventum Corporation (SOLV) is a publicly traded Healthcare sector company. As of May 21, 2026, SOLV trades at $76.13 with a market cap of $13.18B and a P/E ratio of 9.25. SOLV moved +1.79% today. Year to date, SOLV is -5.78%; over the trailing twelve months it is +1.91%. Its 52-week range spans $60.70 to $88.20. Analyst consensus is buy with an average price target of $82.70. Rallies surfaces SOLV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns SOLV stock?

Hedge funds tracked by Rallies that own SOLV include Trian Fund, Baupost Group, Pinebridge Investments, Soros Fund, and Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Solventum Corporation.

SOLV Key Metrics

Key financial metrics for SOLV
Metric	Value
Price	$76.13
Market Cap	$13.18B
P/E Ratio	9.25
EPS	$8.21
Dividend Yield	0.00%
52-Week High	$88.20
52-Week Low	$60.70
Volume	992.44K
Avg Volume	0
Revenue (TTM)	$8.26B
Net Income	$1.43B
Gross Margin	53.67%

Top Hedge Funds Holding SOLV

Trian Fund holds 8.24M shares of SOLV, changed +0.00% as of Mar 31, 2026.
Baupost Group holds 1.05M shares of SOLV, changed -27.18% as of Mar 31, 2025.
Pinebridge Investments holds 31.63K shares of SOLV, changed -83.38% as of Jun 30, 2025.
Soros Fund holds 30.00K shares of SOLV, changed +200.00% as of Jun 30, 2024.
Panagora Asset holds 5.82K shares of SOLV, changed +30.70% as of Mar 31, 2025.

Latest SOLV News

Solventum jumps after Q1 beat, nudges 2026 adjusted EPS toward high end — May 6, 2026
Solventum jumps after Q1 EPS beat, reaffirms 2026 outlook and flags high-end EPS — May 5, 2026
Solventum slides 3% as KeyBanc trims price target ahead of May 5 earnings — Apr 28, 2026
Solventum Q1 Report Set for May 5; Analysts Flag 58% EPS Overstatement — Apr 14, 2026
Solventum jumps as KeyBanc upgrade spotlights discounted medtech valuation — Apr 8, 2026

Recent SOLV Insider Trades

Wendell Amy McBride bought 1.48K (~$100.34K) on Mar 10, 2026.
3M CO sold 8.80M (~$646.36M) on Aug 15, 2025.

SOLV Analyst Consensus

12 analysts cover SOLV: 0 strong buy, 7 buy, 3 hold, 2 sell, 0 strong sell. Consensus rating is buy. Average price target: $82.70.

Common questions about SOLV

Who owns SOLV stock?: Hedge funds tracked by Rallies that own SOLV include Trian Fund, Baupost Group, Pinebridge Investments, Soros Fund, and Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Solventum Corporation.
Does Rallies show 13F holders for SOLV?: Yes. Rallies tracks hedge fund and 13F ownership data for SOLV, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SOLV research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SOLV. It does not provide personalized investment advice.